PRISMATIC AI Trademark

Trademark Overview


On Thursday, July 28, 2022, a trademark application was filed for PRISMATIC AI with the United States Patent and Trademark Office. The USPTO has given the PRISMATIC AI trademark a serial number of 97524409. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, March 21, 2024. This trademark is owned by Zephyr AI, Inc.. The PRISMATIC AI trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer software, downloadable computer software platforms, downloadable mobile applications, and downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals

Scientific research consulting services in the field of genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research consulting; scientific services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, oncological and diabetes-related data; genetic and tumor mapping for scientific and medical purposes; providing scientific research information in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; drug discovery services; pharmaceutical services, namely, providing an online searchable database in the fields of genetics, oncology, and diabetes for scientific research purposes and treatment and diagnostic purposes; scientific research services, namely, analyzing genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scient...
prismatic ai

General Information


Serial Number97524409
Word MarkPRISMATIC AI
Filing DateThursday, July 28, 2022
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, March 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Goods and ServicesDownloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer software, downloadable computer software platforms, downloadable mobile applications, and downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals
Disclaimer with Predetermined Text"AI"
Goods and ServicesScientific research consulting services in the field of genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research consulting; scientific services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, oncological and diabetes-related data; genetic and tumor mapping for scientific and medical purposes; providing scientific research information in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; drug discovery services; pharmaceutical services, namely, providing an online searchable database in the fields of genetics, oncology, and diabetes for scientific research purposes and treatment and diagnostic purposes; scientific research services, namely, analyzing genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scientific and clinical research and scientific consulting services by using machine learning and artificial intelligence technology in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research and consulting, namely, designing and supporting clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services, namely, services using computer algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer, diabetes, and other diseases; pharmaceutical drug development services; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations; consulting services in the field of pharmaceutical research and development; providing temporary use of online non-downloadable software and software platforms featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; providing a web site featuring temporary use of non-downloadable software featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; software design and development; computer software installation and maintenance; DNA analysis services for scientific research purposes; application service provider (ASP) featuring software using artificial intelligence for machine learning

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code8 - Abandoned
Class Status DateThursday, March 21, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateThursday, March 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZephyr AI, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75219

Party NameZephyr AI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75219

Trademark Events


Event DateEvent Description
Thursday, March 21, 2024ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Thursday, March 21, 2024ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, March 21, 2024OPPOSITION TERMINATED NO. 999999
Thursday, March 21, 2024OPPOSITION SUSTAINED NO. 999999
Thursday, December 21, 2023OPPOSITION INSTITUTED NO. 999999
Wednesday, September 20, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 6, 2023NON-FINAL ACTION E-MAILED
Thursday, April 6, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 5, 2023ASSIGNED TO EXAMINER
Monday, August 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 1, 2022NEW APPLICATION ENTERED